Thursday, September 07, 2017 12:48:59 PM
Well, sorry MintMoonDog, but 1) bankruptcies happen all the time of companies that are viable.
Want a running list:
Off the top of my memory, there's K-Mart, American Airlines Fremont General, Calpine, Mirant, Ultra Petroleum, Halcon, etc, etc. And that is all in the last few years.
Want me to keep going?
There are two types of bankruptcy:
1) Insolvency. This is when assets are less than liabilities.
2) Cash Flow: This is when assets may exceed liabilities but the company lacks the cash to pay current debt or continue operations.
It's like if I have a house worth $5M but I have $500 in the bank, and I owe $500k on my credit card.
I might have to declare bankruptcy even though I have assets that can satisfy my debt, but the assets aren't immediately liquid.
I can't believe I have to explain this to you. Actually, I can. You were wrong the last time about DCTH, and you sold your shares and now you're back acting like something other than a trader.
I'm happy to continue this discussion, but I really don't want to embarrass your lack of understanding and business acumen any more than necessary.
Want a running list:
Off the top of my memory, there's K-Mart, American Airlines Fremont General, Calpine, Mirant, Ultra Petroleum, Halcon, etc, etc. And that is all in the last few years.
Want me to keep going?
There are two types of bankruptcy:
1) Insolvency. This is when assets are less than liabilities.
2) Cash Flow: This is when assets may exceed liabilities but the company lacks the cash to pay current debt or continue operations.
It's like if I have a house worth $5M but I have $500 in the bank, and I owe $500k on my credit card.
I might have to declare bankruptcy even though I have assets that can satisfy my debt, but the assets aren't immediately liquid.
I can't believe I have to explain this to you. Actually, I can. You were wrong the last time about DCTH, and you sold your shares and now you're back acting like something other than a trader.
I'm happy to continue this discussion, but I really don't want to embarrass your lack of understanding and business acumen any more than necessary.
Recent DCTH News
- Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/15/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:47:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 12:23:52 PM
- Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference • Business Wire • 05/12/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 01:09:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 12:12:12 PM
- Delcath Systems Reports First Quarter 2026 Results and Business Highlights • Business Wire • 05/07/2026 12:00:00 PM
- Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 • Business Wire • 05/07/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:12:24 PM
- Delcath Systems to Host First Quarter 2026 Earnings Call • Business Wire • 04/23/2026 12:30:00 PM
- Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma • Business Wire • 04/06/2026 12:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 12:56:15 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 12:55:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 12:52:52 PM
- Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting • Business Wire • 04/01/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:22:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 09:48:16 PM
- Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology • Business Wire • 03/03/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 02:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:06:06 PM
